https://orcid.org/0000-0002-7220-0656
Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Mohamed Ouknin, Yin Yang, Jean Costa & Lhou Majidi. (2022) An Investigation into Corsican Honey: Chemical Composition and Biological Activities. Journal of Biologically Active Products from Nature 12:6, pages 474-487.
Read now
Read now
Articles from other publishers (20)
Jiwei Jiang, Hanping Shi, Shirui Jiang, Anxin Wang, Xinying Zou, Yanli Wang, Wenyi Li, Yuan Zhang, Mengfan Sun, Qiwei Ren & Jun Xu. (2023) Nutrition in Alzheimer’s disease: a review of an underappreciated pathophysiological mechanism. Science China Life Sciences 66:10, pages 2257-2279.
Crossref
Crossref
Boriss Sagalajev, Lina Lennartz, Lukas Vieth, Cecilia Tasya Gunawan, Bernd Neumaier, Alexander Drzezga, Veerle Visser-Vandewalle, Heike Endepols & Thibaut Sesia. (2023) TgF344-AD Rat Model of Alzheimer’s Disease: Spatial Disorientation and Asymmetry in Hemispheric Neurodegeneration. Journal of Alzheimer's Disease Reports, pages 1-10.
Crossref
Crossref
Robert P. Friedland & Bodduluri Haribabu. (2023) Neurodegenerative diseases: from gut-brain axis to brain microbiome. Frontiers in Aging Neuroscience 15.
Crossref
Crossref
Britney N. Lizama, Jennifer Kahle, Susan M. Catalano, Anthony O. Caggiano, Michael Grundman & Mary E. Hamby. (2023) Sigma-2 Receptors—From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases. International Journal of Molecular Sciences 24:7, pages 6251.
Crossref
Crossref
Samantha Roudi, Julia Anna Rädler & Samir El Andaloussi. 2023. Precision Medicine in Neurodegenerative Disorders, Part II. Precision Medicine in Neurodegenerative Disorders, Part II
243
266
.
Christian BehlChristian Behl. 2023. Alzheimer’s Disease Research. Alzheimer’s Disease Research
309
350
.
Marta Sochocka, Michał Ochnik, Maciej Sobczyński, Beata Orzechowska & Jerzy Leszek. (2022) Sex Differences in Innate Immune Response of Peripheral Blood Leukocytes of Alzheimer’s Disease Patients. Archivum Immunologiae et Therapiae Experimentalis 70:1.
Crossref
Crossref
Alejandro Marmolejo-Garza, Tiago Medeiros-Furquim, Ramya Rao, Bart J.L. Eggen, Erik Boddeke & Amalia M. Dolga. (2022) Transcriptomic and epigenomic landscapes of Alzheimer's disease evidence mitochondrial-related pathways. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1869:10, pages 119326.
Crossref
Crossref
Leonard A. Levin, Christopher Patrick, Nozhat B. Choudry, Najam A. Sharif & Jeffrey L. Goldberg. (2022) Neuroprotection in neurodegenerations of the brain and eye: Lessons from the past and directions for the future. Frontiers in Neurology 13.
Crossref
Crossref
Clara Ballerini, Alfred K. Njamnshi, Sharon L. Juliano, Rajesh N. Kalaria, Roberto Furlan & Rufus O. Akinyemi. (2022) Non-Communicable Neurological Disorders and Neuroinflammation. Frontiers in Immunology 13.
Crossref
Crossref
Sara Tucker Edmister, Thaís Del Rosario Hernández, Rahma Ibrahim, Cameron A. Brown, Sayali V. Gore, Rohit Kakodkar, Jill A. Kreiling & Robbert Creton. (2022) Novel use of FDA-approved drugs identified by cluster analysis of behavioral profiles. Scientific Reports 12:1.
Crossref
Crossref
Mona Sohrabi, Bijayani Sahu, Harpreet Kaur, Wendie A. Hasler, Atish Prakash & Colin K. Combs. (2022) Gastrointestinal Changes and Alzheimer's Disease. Current Alzheimer Research 19:5, pages 335-350.
Crossref
Crossref
Stefan J. Hermans, Tracy L. Nero, Craig J. Morton, Jonathan H. Gooi, Gabriela A. N. Crespi, Nancy C. Hancock, Chen Gao, Kenta Ishii, Jasmina Markulić & Michael W. Parker. (2021) Structural biology of cell surface receptors implicated in Alzheimer’s disease. Biophysical Reviews 14:1, pages 233-255.
Crossref
Crossref
Filomena Lo Vecchio, Paola Bisceglia, Bruno Pietro Imbimbo, Madia Lozupone, Raffaela Rita Latino, Emanuela Resta, Maurizio Leone, Vincenzo Solfrizzi, Antonio Greco, Antonio Daniele, Mark Watling, Francesco Panza & Davide Seripa. (2022) Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease?. Therapeutic Advances in Chronic Disease 13, pages 204062232210816.
Crossref
Crossref
Gabriel A. de Erausquin, Heather Snyder, Traolach S. Brugha, Sudha Seshadri, Maria Carrillo, Rajesh Sagar, Yueqin Huang, Charles Newton, Carmela Tartaglia, Charlotte Teunissen, Krister Håkanson, Rufus Akinyemi, Kameshwar Prasad, Giovanni D'Avossa, Gabriela Gonzalez‐Aleman, Akram Hosseini, George D. Vavougios, Perminder Sachdev, John Bankart, Niels Peter Ole Mors, Richard Lipton, Mindy Katz, Peter T. Fox, Mohammad Zia Katshu, M. Sriram Iyengar, Galit Weinstein, Hamid R. Sohrabi, Rachel Jenkins, Dan J. Stein, Jacques Hugon, Venetsanos Mavreas, John Blangero, Carlos Cruchaga, Murali Krishna, Ovais Wadoo, Rodrigo Becerra, Igor Zwir, William T. Longstreth, Golo Kroenenberg, Paul Edison, Elizabeta Mukaetova‐Ladinska, Ekkehart Staufenberg, Mariana Figueredo‐Aguiar, Agustín Yécora, Fabiana Vaca, Hernan P. Zamponi, Vincenzina Lo Re, Abdul Majid, Jonas Sundarakumar, Hector M. Gonzalez, Mirjam I. Geerlings, Ingmar Skoog, Alberto Salmoiraghi, Filippo Martinelli Boneschi, Vibuthi N. Patel, Juan M. Santos, Guillermo Rivera Arroyo, Antonio Caballero Moreno, Pascal Felix, Carla Gallo, Hidenori Arai, Masahito Yamada, Takeshi Iwatsubo, Malveeka Sharma, Nandini Chakraborty, Catterina Ferreccio, Dickens Akena, Carol Brayne, Gladys Maestre, Sarah Williams Blangero, Luis I. Brusco, Prabha Siddarth, Timothy M. Hughes, Alfredo Ramírez Zuñiga, Joseph Kambeitz, Agustin Ruiz Laza, Norrina Allen, Stella Panos, David Merrill, Agustín Ibáñez, Debby Tsuang, Nino Valishvili, Srishti Shrestha, Sophia Wang, Vasantha Padma, Kaarin J. Anstey, Vijayalakshmi Ravindrdanath, Kaj Blennow, Paul Mullins, Emilia Łojek, Anand Pria, Thomas H. Mosley, Penny Gowland, Timothy D. Girard, Richard Bowtell & Farhaan S. Vahidy. (2022) Chronic neuropsychiatric sequelae of SARS‐CoV‐2: Protocol and methods from the Alzheimer's Association Global Consortium. Alzheimer's & Dementia: Translational Research & Clinical Interventions 8:1.
Crossref
Crossref
Girdhari Lal Gupta & Nikita Patil Samant. (2021) Current druggable targets for therapeutic control of Alzheimer's disease. Contemporary Clinical Trials 109, pages 106549.
Crossref
Crossref
Adam Jarmuła, Jan Ludwiczak & Dariusz Stępkowski. (2021) β‐sheet breakers with consecutive phenylalanines: Insights into mechanism of dissolution of β‐amyloid fibrils. Proteins: Structure, Function, and Bioinformatics 89:7, pages 762-780.
Crossref
Crossref
Tatiana Karelina, Stepan Lerner, Alexandr Stepanov, Mark Meerson & Oleg Demin. (2021) Monoclonal antibody therapy efficacy can be boosted by combinations with other treatments: Predictions using an integrated Alzheimer’s Disease Platform. CPT: Pharmacometrics & Systems Pharmacology 10:6, pages 543-550.
Crossref
Crossref
Wenyan Zhang, Shuoyan Xu, Hongmei Yu, Xuena Li, Zhuangzhuang Jin, Yaming Li & Zhiyi He. (2021) Radioactive synthesis of tau PET imaging agent 18F-AV-1451 and its role in monitoring the progression of Alzheimer’s disease and supporting differential diagnosis. Annals of Nuclear Medicine 35:2, pages 139-147.
Crossref
Crossref
Mengtian Guo, Zhenyu Yin, Fanglian Chen & Ping Lei. (2020) Mesenchymal stem cell-derived exosome: a promising alternative in the therapy of Alzheimer’s disease. Alzheimer's Research & Therapy 12:1.
Crossref
Crossref